Enterobacteriaceae
1. Describe the general characteristics of the Enterobacteriaceae, including oxygenation, microscopic Gram staining characteristics, and macroscopic appearance on blood and MacConkey agar.
2. Describe the chemical principle of the media used for the isolation and differentiation of Enterobacteriaceae, including xylose-lysine-deoxycholate agar (XLD), Salmonella-Shigella agar (SS), Hektoen enteric agar (HE), MacConkey agar (MAC), eosin methylene blue agar (EMB), cefsulodin-irgasan-novobiocin agar (CIN), Simmons citrate agar (CIT), gram-negative broth (GN), MacConkey agar with sorbitol (MAC-SOR), lysine iron agar (LIA), and triple sugar iron agar (TSI).
3. Describe the antigens used for serotyping in Enterobacteriaceae, including bacterial location, chemical structure, heat stability, and nomenclature.
4. List the members of the Enterobacteriaceae that are considered intestinal pathogens (rather than extraintestinal pathogens).
5. Compare and contrast infections with the various pathotypes of Escherichia coli (i.e., uropathogenic E. coli [UPEC], meningitis/sepsis–associated E. coli [MNEC], enterotoxigenic E. coli [ETEC], enteroinvasive E. coli [EIEC], enteroaggregative E. coli [EAEC], enteropathogenic E. coli [EPEC], and enterohemorrhagic E. coli [EHEC]), including the route of transmission, types of infection, and pathogenesis.
6. Explain the clinical significance of E. coli O157:H7 and the recommended diagnostic testing for confirmation of infection.
7. Outline the basic biochemical testing procedure to differentiate Enterobacteriaceae from other gram-negative rods.
8. Define ESBL and interpret an antibiotic profile as either positive, negative for ESBL, including corrections required before reporting results.
9. Define MDRTF and the antibiotic susceptibility recommendations associated with identification of an MDRTF isolate.
10. Define an extended spectrum cephalosporin resistance and explain the clinical significance and identification in the clinical laboratory.
11. Describe the modified Hodge test (MHT) procedure, including the chemical principle and clinical significance of the test with regard to carbapenemase resistance.
12. Differentiate Salmonella spp. and Shigella spp. based on biochemical testing.
13. Differentiate Yersinia spp. from the major pathogens among the Enterobacteriaceae.
14. Correlate signs and symptoms of infection with the results of laboratory diagnostic procedures for the identification of a clinical isolate in the Enterobacteriaceae family.
Epidemiology
Enterobacteriaceae inhabit a wide variety of niches, including the human gastrointestinal tract, the gastrointestinal tract of other animals, and various environmental sites. Some are agents of zoonoses, causing infections in animal populations (Table 20-1). Just as the reservoirs for these organisms vary, so do their modes of transmission to humans.
TABLE 20-1
Epidemiology of Clinically Relevant Enterobacteriaceae
Organism | Habitat (Reservoir) | Mode of Transmission |
Escherichia coli | Normal bowel flora of humans and other animals; may also inhabit female genital tract | Varies with the type of infection. For nongastrointestinal infections, organisms may be endogenous or spread person to person, especially in the hospital setting. For gastrointestinal infections, the transmission mode varies with the strain of E. coli (see Table 20-2); it may involve fecal-oral spread between humans in contaminated food or water or consumption of undercooked beef or unpasteurized milk from colonized cattle |
Shigella spp. | Only found in humans at times of infection; not part of normal bowel flora | Person-to-person spread by fecal-oral route, especially in overcrowded areas, group settings (e.g., daycare) and areas with poor sanitary conditions |
Salmonella serotype Typhi Salmonella serotypes Paratyphi A, B, C |
Only found in humans but not part of normal bowel flora | Person-to-person spread by fecal-oral route by ingestion of food or water contaminated with human excreta |
Other Salmonella spp. | Widely disseminated in nature and associated with various animals | Ingestion of contaminated food products processed from animals, frequently of poultry or dairy origin. Direct person-to-person transmission by fecal-oral route can occur in health care settings when hand-washing guidelines are not followed |
Edwardsiella tarda | Gastrointestinal tract of cold-blooded animals, such as reptiles | Uncertain; probably by ingestion of contaminated water or close contact with carrier animal |
Yersinia pestis | Carried by urban and domestic rats and wild rodents, such as the ground squirrel, rock squirrel, and prairie dog | From rodents to humans by the bite of flea vectors or by ingestion of contaminated animal tissues; during human epidemics of pneumonic (i.e., respiratory) disease, the organism can be spread directly from human to human by inhalation of contaminated airborne droplets; rarely transmitted by handling or inhalation of infected animal tissues or fluids |
Yersinia enterocolitica | Dogs, cats, rodents, rabbits, pigs, sheep, and cattle; not part of normal human microbiota | Consumption of incompletely cooked food products (especially pork), dairy products such as milk, and, less commonly, by ingestion of contaminated water or by contact with infected animals |
Yersinia pseudotuberculosis | Rodents, rabbits, deer, and birds; not part of normal human microbiota | Ingestion of organism during contact with infected animal or from contaminated food or water |
Citrobacter spp., Enterobacter spp., Klebsiella spp., Morganella spp., Proteus spp., Providencia spp., and Serratia spp. | Normal human gastrointestinal microbiota | Endogenous or person-to-person spread, especially in hospitalized patients |
Pathogenesis and Spectrum of Diseases
The clinically relevant members of the Enterobacteriaceae can be considered as two groups: the opportunistic pathogens and the intestinal pathogens. Typhi and Shigella spp. are among the latter group and are causative agents of typhoid fever and dysentery, respectively. Yersinia pestis is not an intestinal pathogen, but it is the causative agent of plague. The identification of these organisms in clinical material is serious and always significant. These organisms, in addition to others, produce various potent virulence factors and can cause life-threatening infections (Table 20-2).
TABLE 20-2
Pathogenesis and Spectrum of Disease for Clinically Relevant Enterobacteriaceae
Organism | Virulence Factors | Spectrum of Disease and Infections |
Escherichia coli (as a cause of extraintestinal infections) | Several, including endotoxin, capsule production pili that mediate attachment to host cells | Urinary tract infections, bacteremia, neonatal meningitis, and nosocomial infections of other various body sites. Most common cause of gram-negative nosocomial infections. |
Enterotoxigenic E. coli (ETEC) | Pili that permit gastrointestinal colonization. Heat-labile (LT) and heat-stable (ST) enterotoxins that mediate secretion of water and electrolytes into the bowel lumen | Traveler’s and childhood diarrhea, characterized by profuse, watery stools. Transmitted by contaminated food and water. |
Enteroinvasive E. coli (EIEC) | Virulence factors uncertain, but organism invades enterocytes lining the large intestine in a manner nearly identical to Shigella | Dysentery (i.e., necrosis, ulceration, and inflammation of the large bowel); usually seen in young children living in areas of poor sanitation. |
Enteropathogenic E. coli (EPEC) | Bundle-forming pilus, intimin, and other factors that mediate organism attachment to mucosal cells of the small bowel, resulting in changes in cell surface (i.e., loss of microvilli) | Diarrhea in infants in developing, low-income nations; can cause a chronic diarrhea. |
Enterohemorrhagic E. coli (EHEC, VTEC, or STEC) | Toxin similar to Shiga toxin produced by Shigella dysenteriae. Most frequently associated with certain serotypes, such as E. coli O157:H7 | Inflammation and bleeding of the mucosa of the large intestine (i.e., hemorrhagic colitis); can also lead to hemolytic-uremic syndrome, resulting from toxin-mediated damage to kidneys. Transmitted by ingestion of undercooked ground beef or raw milk. |
Enteroaggregative E. coli (EAEC) | Probably involves binding by pili, ST-like, and hemolysin-like toxins; actual pathogenic mechanism is unknown | Watery diarrhea that in some cases can be prolonged. Mode of transmission is not well understood. |
Shigella spp. | Several factors involved to mediate adherence and invasion of mucosal cells, escape from phagocytic vesicles, intercellular spread, and inflammation. Shiga toxin role in disease is uncertain, but it does have various effects on host cells. | Dysentery defined as acute inflammatory colitis and bloody diarrhea characterized by cramps, tenesmus, and bloody, mucoid stools. Infections with S. sonnei may produce only watery diarrhea. |
Salmonella serotypes | Several factors help protect organisms from stomach acids, promote attachment and phagocytosis by intestinal mucosal cells, allow survival in and destruction of phagocytes, and facilitate dissemination to other tissues. | Three general categories of infection are seen:
• Gastroenteritis and diarrhea caused by a wide variety of serotypes that produce infections limited to the mucosa and submucosa of the gastrointestinal tract. S. serotype Typhimurium and S. serotype Enteritidis are the serotypes most commonly associated with Salmonella gastroenteritis in the United States. • Bacteremia and extraintestinal infections occur by spread from the gastrointestinal tract. These infections usually involve S. Choleraesuis or S. dublin, although any serotype may cause these infections. • Enteric fever (typhoid fever, or typhoid) is characterized by prolonged fever and multisystem involvement, including blood, lymph nodes, liver, and spleen. This life-threatening infection is most frequently caused by S. serotype Typhi; more rarely, S. serotypes Paratyphi A, B or C. |
Specific Organisms
Opportunistic Human Pathogens
Citrobacter spp. (C. freundii, C. koseri, C. braakii)
Citrobacter organisms are inhabitants of the intestinal tract. The most common clinical manifestation in patients as a result of infection occurs in the urinary tract. However, additional infections, including septicemias, meningitis, brain abscesses, and neurologic complications, have been associated with Citrobacter spp. Transmission is typically person to person. Table 20-3 provides an outline of the biochemical differentiation of the most common clinically isolated Citrobacter species. C. freundii may harbor inducible AmpC genes that encode resistance to ampicillin and first-generation cephalosporins.
TABLE 20-3
Biochemical Differentiation of Citrobacter Species
Species | Indole | ODC | Malonate | ACID FERMENTATION | |||
Adonitol | Dulcitol | Melibiose | Sucrose | ||||
C. braakii | V | pos | neg | neg | V | V | neg |
C. freundii | V | neg | neg | neg | neg | pos | V |
C. koseri | pos | pos | pos | pos | V | neg | V |
neg, Negative < 15%; ODC, ornithine decarboxylase; pos, positive ≥ 85%; V, variable 15% to 84%.
From Versalovic J: Manual of clinical microbiology, ed 10, 2011, Washington, DC, ASM Press.
Plesiomonas shigelloides
P. shigelloides is unusual in that it is among the few species of clinically relevant bacteria that decarboxylate lysine, ornithine, and arginine. It is important to distinguish Aeromonas spp. from P. shigelloides., since both are oxidase positive. This is accomplished by using the string test described in Chapter 26. The DNase test may also be used to differentiate these organisms. Aeromonas spp. are DNase positive and Plesiomonas organisms are DNase negative.
Laboratory Diagnosis
Specimen Collection and Transport
Enterobacteriaceae are typically isolated from a variety of sources in combination with other more fastidious organisms. No special considerations are required for specimen collection and transport of the organisms discussed in this chapter. (See Table 5-1 for general information on specimen collection and transport.)
Specimen Processing
No special considerations are required for processing of the great majority of organisms discussed in this chapter. The one exception is Yersinia pestis. This organism is a select agent. Manipulation of specimens suspected of containing this organism would generate aerosols and should be handled using Biosafety Level 3 (BSL-3) conditions. Refer to Table 5-1 for general information on specimen processing.
Cultivation
Media of Choice
Most Enterobacteriaceae grow well on routine laboratory media, such as 5% sheep blood, chocolate, and MacConkey agars. In addition to these media, selective agars, such as Hektoen enteric (HE) agar, xylose-lysine-deoxycholate (XLD) agar, and Salmonella–Shigella (SS) agar, are commonly used to cultivate enteric pathogens from gastrointestinal specimens (see Chapter 59 for more information about laboratory procedures for the diagnosis of bacterial gastrointestinal infections). The broths used in blood culture systems, as well as thioglycollate and brain-heart infusion broths, all support the growth of Enterobacteriaceae.
Table 20-4 presents a complete description of the laboratory media used to isolate Enterobacteriaceae.
TABLE 20-4
Biochemical Media used in the Differentiation and Isolation of Enterobacteriaceae
Media | Selective | Differential | Nutritional | Purpose |
Blood agar (sheep) (SBA, BAP) | Hemolysis of RBCs: | Routinely used to cultivate moderately fastidious organisms; TSA with 5% to 10% defibrinated blood. | Screening colonies for the oxidase enzyme | |
Cefsulodin-irgasan-novobiocin agar (CIN) | Selective inhibition of gram-negative and gram-positive organisms | Fermentation of mannitol in the presence of neutral red. Macroscopic colonial appearance: colorless or pink colonies with red center. | Isolation of Yersinia enterocolitica |